IDRA Historical Earnings image   This IDRA historical earnings page last updated 1/20/2023
IDRA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/14/20220.05M
Q2 20228/9/2022NA
Q1 20225/5/2022NA
Q4 20213/31/2022NA
Q3 202111/8/2021NA
Q2 20218/9/2021NA
Q1 20214/29/2021NA
Q4 20203/1/2021NA
Q3 202010/29/2020NA
Q2 20208/4/2020NA
Q1 20204/30/2020NA
Q4 20193/12/2020NA
Q3 201911/6/2019NA
Q2 20198/8/20190.00B
Q1 20195/2/2019NA
Q4 20183/6/201999000
Q3 201811/6/2018145000
Q2 20188/2/2018163000
Q1 20185/9/2018255000
Q4 20173/7/2018173000
Q3 201711/6/2017164000
Q2 20178/7/2017187000
Q1 20175/4/2017378000
Q4 20163/15/201715.28M
Q3 201610/28/2016323000
Q2 20168/2/2016301000
Q1 20165/9/2016294000
Q4 20153/10/2016190000
Q3 201511/6/201520000
Q2 20158/6/20155000
Q1 20155/11/201534000
Q4 20143/12/20152000
Q3 201411/7/201430000
Q2 20148/12/201438000
Q1 20145/13/20143000
Q4 20133/13/20140.00M
Q3 201311/14/20130.01M
Q2 20138/15/20130.03M
Q1 20135/15/20130.01M
Q4 20123/11/20130.01M
Q3 201211/12/20120.00M
Q2 20128/9/20120.03M
IDRA Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/14/2022-1.020
Q2 20228/9/2022-1.700
Q1 20225/5/2022-1.360
Q4 20213/31/2022-1.360
Q3 202111/8/2021-1.870
Q2 20218/9/2021-2.210
Q1 20214/29/2021-4.080
Q4 20203/1/2021-3.740
Q3 202010/29/2020-3.570
Q2 20208/4/2020-4.080
Q1 20204/30/20203.740
Q4 20193/12/2020-6.800
Q3 201911/6/2019-6.630
Q2 20198/8/2019-6.630
Q1 20195/2/2019-6.630
Q4 20183/6/2019-7.650
Q3 201811/6/2018-7.310
Q2 20188/2/2018-10.030
Q1 20185/9/2018-13.600
Q4 20173/7/2018-10.880
Q3 201711/6/2017-13.600
Q2 20178/7/2017-19.040
Q1 20175/4/2017-13.600
Q4 20163/15/20171.360
Q3 201610/28/2016-13.600
Q2 20168/2/2016-14.960
Q1 20165/9/2016-14.960
Q4 20153/10/2016-13.600
Q3 201511/6/2015-13.600
Q2 20158/6/2015-14.960
Q1 20155/11/2015-16.320
Q4 20143/12/2015-19.040
Q3 201411/7/2014-14.960
Q2 20148/12/2014-13.600
Q1 20145/13/2014-16.320
Q4 20133/13/2014-13.600
Q3 201311/14/2013-14.960
Q2 20138/15/2013-20.400
Q1 20135/15/2013-20.400
Q4 20123/11/2013-32.640
Q3 201211/12/2012-23.120
Q2 20128/9/2012-20.400
Quotes delayed 20 minutes

Email EnvelopeFree IDRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Idera Pharmaceuticals (IDRA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

IDXX Historical Earnings
IDYA Historical Earnings
IGMS Historical Earnings
IIN Historical Earnings
IKNA Historical Earnings
IKT Historical Earnings
ILMN Historical Earnings
IMAC Historical Earnings
IMGN Historical Earnings
IMGO Historical Earnings
What was the record high IDRA historical earnings result?
In terms of earnings or revenue, what is the best IDRA historical earnings result that Idera Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest IDRA historical earnings result was set in Q1 2020, when Idera Pharmaceuticals posted results of 3.740/share. The most successful revenue quarter within our data set was Q4 2016 when Idera Pharmaceuticals reported revenue of 15.28M.

What was the lowest Idera Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest IDRA has reported, and when?

✔️Accepted answer: Within our data set, the lowest IDRA historical earnings result was set in Q4 2012, when Idera Pharmaceuticals posted results of -32.640/share. The smallest revenue quarter within our data set was Q2 2022 when Idera Pharmaceuticals reported revenue of NA.

On this page we presented the IDRA historical earnings date information for Idera Pharmaceuticals. Reviewing that IDRA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2020, when IDRA posted gaap of 3.740/share. Meanwhile the lowest IDRA historical earnings result was in Q4 2012, when IDRA posted gaap of -32.640/share. Moving to Idera Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2016 when IDRA reported 15.28M in revenue, while the smallest revenue quarter was Q2 2022 when IDRA reported NA in revenue.

For self directed investors doing their due diligence on IDRA or any other given stock, their research can benefit from looking into all of the Idera Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Idera Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for IDRA. Thanks for visiting, and the next time you need to research IDRA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of MCQ, Funds Holding NATL, Top Ten Hedge Funds Holding CMPX.

 

IDRA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.